Agilent Technologies (NYSE:A) Price Target Raised to $190.00

Key Points

• Citigroup raised Agilent Technologies’ price target to $190 from $185 and maintained a “buy” rating, implying 20.85% upside from the prior close.
• Agilent beat quarterly expectations with $1.62 adjusted EPS and $1.88 billion in revenue, up 8.1% year over year, and raised its fiscal 2026 earnings and revenue outlook.
• Analyst sentiment remains broadly positive: 16 analysts rate the stock a Strong Buy or Buy, while the average price target is $170.33; shares recently traded at $157.22.

Agilent Technologies (NYSE:A - Get Free Report) had its price objective lifted by equities researchers at Citigroup from $185.00 to $190.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has a "buy" rating on the medical research company's stock. Citigroup's price target suggests a potential upside of 20.85% from the stock's previous close.

Several other analysts have also recently issued reports on A. HSBC dropped their target price on Agilent Technologies from $180.00 to $165.00 and set a "buy" rating for the company in a report on Wednesday, June 3rd. Wells Fargo & Company lowered their price target on Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating for the company in a report on Thursday, May 28th. TD Cowen raised their price target on Agilent Technologies from $155.00 to $180.00 and gave the stock a "buy" rating in a research note on Thursday. Stifel Nicolaus raised their price target on Agilent Technologies from $170.00 to $180.00 and gave the stock a "buy" rating in a report on Thursday. Finally, JPMorgan Chase & Co. increased their price objective on Agilent Technologies from $180.00 to $190.00 and gave the stock an "overweight" rating in a research report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $170.33.

Agilent Technologies Stock Performance

NYSE A traded up $2.13 during mid-day trading on Thursday, reaching $157.22. 1,992,931 shares of the stock were exchanged, compared to its average volume of 2,232,849. The company has a market capitalization of $44.40 billion, a P/E ratio of 31.56, a P/E/G ratio of 2.73 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The business's 50 day moving average is $139.16 and its 200-day moving average is $126.65. Agilent Technologies has a 1 year low of $108.35 and a 1 year high of $163.75.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping analysts' consensus estimates of $1.49 by $0.13. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company's revenue was up 8.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, equities research analysts forecast that Agilent Technologies will post 6.05 EPS for the current fiscal year.

Hedge Funds Weigh In On Agilent Technologies

A number of large investors have recently modified their holdings of A. Core Wealth Advisors LLC acquired a new position in Agilent Technologies during the fourth quarter worth $26,000. SHP Wealth Management acquired a new position in Agilent Technologies during the fourth quarter worth about $26,000. Navalign LLC acquired a new position in Agilent Technologies during the fourth quarter worth $27,000. Cedar Mountain Advisors LLC purchased a new stake in shares of Agilent Technologies in the 1st quarter worth about $27,000. Finally, Markowski Investments purchased a new stake in shares of Agilent Technologies in the second quarter valued at about $27,000. 87.41% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Agilent Technologies

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and above the $1.84 billion consensus estimate. Adjusted EPS of $1.62 also exceeded expectations of $1.49, while earnings rose from $1.37 a year earlier. Operating profit and cash flow improved, supporting the view that demand for laboratory, pharmaceutical research, and analytical instruments is recovering. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
• Positive Sentiment: The company raised its fiscal 2026 outlook to adjusted EPS of $6.18-$6.21, above the $6.06 analyst consensus, and forecast revenue of approximately $7.5 billion versus expectations of $7.4 billion. Fourth-quarter EPS guidance of $1.71-$1.74 was at or above consensus, reinforcing confidence in improving demand and expanding margins. Agilent raises annual profit forecast on improving lab tools demand
• Positive Sentiment: Several analysts raised their price targets and adopted bullish ratings following the results. JPMorgan lifted its target to $190 and rated the stock “overweight”; RBC raised its target to $185 with an “outperform” rating; and TD Cowen and Bernstein increased targets to $180, with “buy” and “outperform” ratings, respectively. The revisions signal that analysts see additional upside after the earnings beat and guidance increase. Analyst price-target revisions reported by Benzinga

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source